European guidelines on achalasia: United European Gastroenterology and European Society of Neurogastroenterology and Motility recommendations
ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth
This guideline statement evaluates criteria for diagnosis, defines the optimal methods for diagnostic testing, and summarizes treatment options for small intestinal bacterial overgrowth.
ESPGHAN New Guidelines for the Diagnosis of Paediatric Coeliac Disease
This advice guide provides new and updated summary guidance from the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) on diagnosing children and adolescents with CD.
ESPGHAN Guidelines for Diagnosing Coeliac Disease
The ESPGHAN 2012 coeliac disease (CD) diagnostic guidelines aimed to guide physicians in accurately diagnosing CD and permit omission of duodenal biopsies in selected cases. Here, an updated and expanded evidence-based guideline is presented.
BSPGHAN Motility Working Group consensus statement- Anorectal manometry in children with defecation disorders
Guidance on the use of ARM/HRAM in children with CC and/or FI.
Management of Exocrine Pancreatic Insufficiency in Children
The diagnosis of exocrine pancreatic insufficiency (EPI) can be difficult, as symptoms may be nonspecific.
Nutrition Management in Acute Pancreatitis
Acute pancreatitis (AP) is one of the most prevalent gastrointestinal conditions necessitating inpatient care.
Chronic Pancreatitis and Nutrition Therapy
Chronic pancreatitis is a complex and irreversible disease of the pancreas and is associated with significant morbidity and mortality.
Practical guide to the management of acute pancreatitis
Position paper discussing current diagnostic and management challenges and addressing the common dilemmas in AP.
2019 WSES guidelines for the management of severe acute pancreatitis
The main topics of these guidelines fall under the following topics: Diagnosis, Antibiotic treatment, Management in the Intensive Care Unit, Surgical and operative management, and Open abdomen.
Part 2: Acute Severe Colitis – An Evidence-based Consensus Guideline From the European Crohn’s and Colitis Organization and the European Society of Paediatric Gastroenterology, Hepatology and Nutrition
These guidelines standardize the management of ASC in children in an attempt to optimize outcomes of this intensive clinical scenario.
Part 1: Ambulatory Care – An Evidence-based Guideline From European Crohn’s and Colitis Organization and European Society of Paediatric Gastroenterology, Hepatology and Nutrition
These guidelines provide a guide to clinicians managing children with UC and IBD-unclassified management to provide modern management strategies while maintaining vigilance around appropriate outcomes and safety issues.
Assessment, monitoring and management of deliberate and accidental paracetamol overdose in Children
Joint Guideline proposed by the Children’s Specialised Liver Services at King’s, Birmingham, and Leeds.
BSG Position Paper: Green Endoscopy
Green endoscopy: British Society of Gastroenterology (BSG), Joint Accreditation Group (JAG) and Centre for Sustainable Health (CSH) joint consensus on practical measures for environmental sustainability in endoscopy.
Management of Exocrine Pancreatic Insufficiency in Children
The diagnosis of exocrine pancreatic insufficiency (EPI) can be difficult, as symptoms may be nonspecific.
Practical guide to the management of acute pancreatitis
Position paper discussing current diagnostic and management challenges and addressing the common dilemmas in AP.
2019 WSES guidelines for the management of severe acute pancreatitis
The main topics of these guidelines fall under the following topics: Diagnosis, Antibiotic treatment, Management in the Intensive Care Unit, Surgical and operative management, and Open abdomen.
Part 1: Ambulatory Care – An Evidence-based Guideline From European Crohn’s and Colitis Organization and European Society of Paediatric Gastroenterology, Hepatology and Nutrition
These guidelines provide a guide to clinicians managing children with UC and IBD-unclassified management to provide modern management strategies while maintaining vigilance around appropriate outcomes and safety issues.
Part 2: Acute Severe Colitis – An Evidence-based Consensus Guideline From the European Crohn’s and Colitis Organization and the European Society of Paediatric Gastroenterology, Hepatology and Nutrition
These guidelines standardize the management of ASC in children in an attempt to optimize outcomes of this intensive clinical scenario.
Paediatric Intestinal Pseudo-obstruction: Evidence and Consensus-based Recommendations From an ESPGHAN-Led Expert Group
This document is intended to be used in daily practice from the time of first presentation and definitive diagnosis PIPO through to the complex management and treatment interventions such as intestinal transplantation.
GI Bleeding Pathway
GI Bleeding pathway details. Pathway to be read in conjunction with Assessment and Management of Oesophageal Varices in Children
Joint NASPGHAN and ESPGHAN guidelines on Gastro-oesophageal Reflux Disease in Children
This document serves as an update of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN) 2009 clinical guidelines for the diagnosis and management of gastroesophageal reflux disease (GERD) in infants and children and is intended to be applied in daily practice and as a basis for clinical trials.
American Gastroenterological Association Institute Guideline on Initial Management of Acute Pancreatitis
This document presents the official recommendations of the American Gastroenterological Association (AGA) on the initial management of acute pancreatitis (AP).
Joint ESPGHAN/NASPGHAN Guidelines for the Management of Helicobacter pylori in Children and Adolescents
The primary goal of clinical investigation is to identify the cause of upper gastrointestinal symptoms rather than H pylori infection. Therefore, we recommend against a test and treat strategy.
BSPGHAN Motility Working Group position statement: paediatric multichannel intraluminal pH impedance monitoring—indications, methods and interpretation
MII-pH is increasingly used by paediatricians as the diagnostic tool for assessing gastro-oesophageal reflux disease and symptom association. There is wide variation in paediatric practice and a need for standardised practice.
LSG|UK Steatotic Liver Guideline 2025-26 Version
This guideline has been designed to aid practitioners in how to proceed when imaging studies identify hepatic steatosis (a bright, hyperechoic liver as compared to the spleen on ultrasound) or raised liver enzymes are detected in an overweight child.
Paediatric Acute Liver Failure Protocol
Acute liver failure (ALF) is a potentially life-threatening condition that necessitates early recognition and optimal management and transfer to a Liver Transplant Centre for further management that might include liver transplantation.
Acute Liver Failure Guidelines by the The American College of Gastroenterology
Acute liver failure (ALF) is a life-threatening condition that occurs in patients with no preexisting liver disease and is characterized by liver injury (abnormal liver tests), coagulopathy (international normalized ratio [INR] .1.5), and hepatic encephalopathy (HE).
Proposed Prolonged Jaundice Pathway following national audit 2022-2023
UK Multi-center practice and adaptation of Guidelines from NICE and Liver centre conjugated hyperbilirubinemia pathway.
AGA Clinical Practice Update on Diagnosis and Management of Acute Hepatic Porphyrias: Expert Review
The acute hepatic porphyrias (AHP) are rare, inborn errors of heme-metabolism and include acute intermittent porphyria, hereditary coproporphyria, variegate porphyria, and porphyria due to severe deficiency of 5-aminolevulinic acid dehydratase.
Early investigation and management of children with acute non-A-E hepatitis, with and without liver failure
This clinical framework is intended to provide a structure for the investigation, transfer and management of children with novel non-A-E acute hepatitis in the context of an emergence of a novel disease. The recommendations within this guidance are based on existing principles of management of acute hepatitis and acute liver failure and on expert consensus opinion in the absence of high quality evidence around this novel condition.
Assessment and Management of Oesophageal Varices in Children
These guidelines were constructed after a joint audit and review of practice at the three specialised centres in June 2016 and reviewed again in 2021. Although evidence based where possible, where not available they represent consensus. A detailed version of this guideline which includes review of evidence, together with reference to adult evidenced based guidelines is available. Section 4: management of acute variceal bleed: is designed for implementation at any hospital to which a child presents and can be used as a stand-alone guideline.
Updated shielding guidance for children with chronic liver disease and those on immunosuppression (autoimmune and liver transplantation
In view of the continuous evidence and increasing knowledge in the COVID-19 pandemic we have undertaken an update on the advice to children and families with chronic liver disease.
NICE and ESPGHAN Guidelines
These guidelines and standards have been published by NICE and ESPGHAN and are available for information. However, please do not hesitate to contact your local Paediatric Hepatology Team to discuss management of a child with any liver disorder.
Investigation of Neonatal Conjugated Jaundice
This guideline aims to advise clinicians on the initial investigations necessary when an infant with conjugated jaundice is identified.
Investigation and treatment of liver disease with acute onset
Defined as EITHER sudden onset of jaundice with evidence of liver aetiology OR incidental discovery of raised transaminases in association with symptoms suggesting acute onset.
ESPGHAN/ESPEN/ESPR/CSPEN guidelines on paediatric parenteral nutrition: Standard versus individualized parenteral nutrition
PN can be provided as a standard, usually commercial, formulation that is designed to meet the nutritional needs of most patients of the same age group with a similar condition.
ESPGHAN/ESPEN/ESPR/CSPEN guidelines on paediatric parenteral nutrition: Lipids
The rate, amount, and type of lipids provided intravenously are important aspects regarding the efficacy and safety in neonates and children.
ESPGHAN/ESPEN/ESPR/CSPEN guidelines on paediatric parenteral nutrition: Iron and trace minerals
Iron is an essential nutrient and iron deficiency results in anemia as well as poor neurodevelopment in children.
ESPGHAN/ESPEN/ESPR/CSPEN guidelines on paediatric parenteral nutrition: Fluid and electrolytes
The aim of the current revision is to update the previous chapter on basis of the scientific evidence published since 2004.
ESPGHAN/ESPEN/ESPR/CSPEN guidelines on paediatric parenteral nutrition: Energy
Energy supply needs to meet the nutritional needs of the patient which include basal metabolic rate, physical activity, growth, diet induced thermogenesis and correction of pre-existing malnutrition.
ESPGHAN/ESPEN/ESPR/CSPEN guidelines on paediatric parenteral nutrition: Carbohydrates
Carbohydrates are the main source of energy in nutrition and usually provide 40-60% of the energy supply in western diets.
ESPGHAN/ESPEN/ESPR/CSPEN guidelines on paediatric parenteral nutrition: Calcium, phosphorus and magnesium
In infants and children growth is the major determinant of mineral requirements.
ESPGHAN/ESPEN/ESPR/CSPEN guidelines on paediatric parenteral nutrition: Amino acids
Recommendations were developed from a standpoint of nutrient adequacy. Depending on age groups, nutrient adequacy was based on intrauterine accretion rate, organ development, factorial estimates of requirements and amino acid interactions. Individual amino acids are discussed.
Recommendations for Nutritional Management of Children with Neurological Impairment (NI)
This guide provides recommendations and a systematic approach for the care of paediatric patients with NI.
Disclaimer: BSPGHAN is not responsible for external content.